Lønning PE - Search Results

1

Breast cancer prognostication and prediction in the postgenomic era.

Lønning PE, Knappskog S, Staalesen V, Chrisanthar R, Lillehaug JR. Lønning PE, et al. Ann Oncol. 2007 Aug;18(8):1293-306. doi: 10.1093/annonc/mdm013. Epub 2007 Feb 21. Ann Oncol. 2007. PMID: 17317675 Free article. Review.

2

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients.

Aas T, Børresen AL, Geisler S, Smith-Sørensen B, Johnsen H, Varhaug JE, Akslen LA, Lønning PE. Aas T, et al. Among authors: lonning pe. Nat Med. 1996 Jul;2(7):811-4. doi: 10.1038/nm0796-811. Nat Med. 1996. PMID: 8673929

3

Aromatase inhibition for breast cancer treatment.

Lønning PE. Lønning PE. Acta Oncol. 1996;35 Suppl 5:38-43. doi: 10.3109/02841869609083966. Acta Oncol. 1996. PMID: 9142963 Review.

4

Exemestane experience in breast cancer treatment.

Lønning PE, Paridaens R, Thürlimann B, Piscitelli G, di Salle E. Lønning PE, et al. J Steroid Biochem Mol Biol. 1997 Apr;61(3-6):151-5. J Steroid Biochem Mol Biol. 1997. PMID: 9365185 Review.

5

Cross-resistance to different aromatase inhibitors in breast cancer treatment.

Lønning PE. Lønning PE. Endocr Relat Cancer. 1999 Jun;6(2):251-7. doi: 10.1677/erc.0.0060251. Endocr Relat Cancer. 1999. PMID: 10731117 Review.

6

Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: a phase II trial.

Lønning PE, Bajetta E, Murray R, Tubiana-Hulin M, Eisenberg PD, Mickiewicz E, Celio L, Pitt P, Mita M, Aaronson NK, Fowst C, Arkhipov A, di Salle E, Polli A, Massimini G. Lønning PE, et al. J Clin Oncol. 2000 Jun;18(11):2234-44. doi: 10.1200/JCO.2000.18.11.2234. J Clin Oncol. 2000. PMID: 10829043 Clinical Trial.

7

Is there a growing role for endocrine therapy in the treatment of breast cancer?

Lønning PE. Lønning PE. Drugs. 2000 Jul;60(1):11-21. doi: 10.2165/00003495-200060010-00002. Drugs. 2000. PMID: 10929927 Review.

8

Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.

Geisler S, Lønning PE, Aas T, Johnsen H, Fluge O, Haugen DF, Lillehaug JR, Akslen LA, Børresen-Dale AL. Geisler S, et al. Among authors: lonning pe. Cancer Res. 2001 Mar 15;61(6):2505-12. Cancer Res. 2001. PMID: 11289122 Clinical Trial.

9

Microarrays in primary breast cancer--lessons from chemotherapy studies.

Lønning PE, Sørlie T, Perou CM, Brown PO, Botstein D, Børresen-Dale AL. Lønning PE, et al. Endocr Relat Cancer. 2001 Sep;8(3):259-63. doi: 10.1677/erc.0.0080259. Endocr Relat Cancer. 2001. PMID: 11566617

10

Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study.

Geisler J, Haynes B, Anker G, Dowsett M, Lønning PE. Geisler J, et al. Among authors: lonning pe. J Clin Oncol. 2002 Feb 1;20(3):751-7. doi: 10.1200/JCO.2002.20.3.751. J Clin Oncol. 2002. PMID: 11821457 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

385 results

Search Page

Filters